Business

Directorate Change

Directorate Change.

articleAdvanced Medical Solutions Group PlcJune 23, 20253/company/advanced-medical-solutions-group-plc/news/directorate-change-958
Directorate Change

About this update from Advanced Medical Solutions Group Plc

[{"type":"text","content":"\n\n \n\n\n\n\n \n\n\n23 June 2025\n\n\n\n\n            Advanced Medical Solutions Group plc\n(\"AMS\", the \"Company\" or the \"Group\")\n \n            Directorate Change\n           \n            Juliet Thompson to be Appointed as an Independent Non-Executive Director\n \nWinsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, is pleased to announce that our search for an additional Independent Non-Executive Director has successfully concluded and that Juliet Thompson will be appointed as a Non-Executive Director and Chair of the Audit Committee following the conclusion of the AGM on 30 June.\n \nJuliet has over 30 years of finance, banking and board experience with significant focus in the healthcare sector. She is a proven FTSE 250 Audit Committee Chair and a former investment banker who has spent her career advising pharmaceutical and medtech companies. She played a leading role in setting up Code Securities, which was later acquired by Nomura (becoming Nomura Code) but remained independent. At Nomura Code, Juliet advised companies in the healthcare and clean tech sectors on their financing and strategic options. She worked on over 50 transactions including IPOs, secondary offerings, private placements and M&A. As Nomura Code was devolved, she joined Stifel with a team from Nomura Code to head up the life sciences team where she advised CEOs and CFOs in the healthcare sector. She was Audit Committee Chair at Vectura Group Limited.\n \nJuliet has built a diverse portfolio; she is currently a Non-Executive Director and Chair of the Audit Committees of: Indivior plc, a NASDAQ listed company working to develop medicines to treat addiction; Novacyt S.A., a Euronext and AIM listed diagnostic company; and Organox Limited, a private company spun out of Oxford University developing innovative solutions for organ preservation prior to transplantation. Juliet holds a BSc in Economics from the University of Bristol and qualified as a Chartered Accountant and holds an ACA from the Association of Chartered...

More updates from Advanced Medical Solutions Group Plc